February 2024 Stock Gainers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2024-02-29, 20 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest losers of February 2024

100

Ranked gains

+1092.05%

Largest, HOLO

93.0%

Above baseline, day +5

4.3%

Median give-back, day +5

Filter and sort

100 ranked gains in February 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	HOLO	+1092.05%	2024-02-07 against the close of 2024-02-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	MicroCloud Hologram Planned to Join the Communications Industry Association 02/07/2024 05:20 ET premarket	Day +1 +1800.66% 2024-02-08 Day +5 +1392.05% 2024-02-14 Best close within 5 +1800.66% 2024-02-08 Five sessions later the move was 27.5% bigger, at +1392.05%. Month end +543.05% on 2024-02-29
Close before and after $1,208.00 to $14,400.00 split-adjusted Session open, high, low $3,008.00, $14,912.00, $2,640.00 Opening gap +149.01% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 242,587 shares, $3,493,252,800 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
2	VANI	+270.30%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio 02/28/2024 08:30 ET premarket	Day +1 +317.82% 2024-02-29 Day +5 +118.81% 2024-03-06 Best close within 5 +317.82% 2024-02-29 56.0% of the move was gone five sessions later. Month end +317.82% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $1.01 to $3.74 split-adjusted Session open, high, low $6.05, $7.80, $3.51 Opening gap +499.01% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 148,811,385 shares, $556,554,580 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
3	JANX	+229.47%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Janux Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for PSMAxCD3-TRACTr JANX007 in mCRPC and EGFRxCD3-TRACTr JANX008 in Solid Tumors 02/26/2024 16:05 ET after hours	Day +1 +208.58% 2024-02-28 Day +5 +186.36% 2024-03-05 Best close within 5 +220.40% 2024-02-29 18.8% of the move was gone five sessions later. Month end +220.40% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $15.10 to $49.75 split-adjusted Session open, high, low $35.79, $52.00, $34.25 Opening gap +137.02% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 15,491,582 shares, $770,706,205 Relative volume 187.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	SCTL	+132.61%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc. 02/28/2024 16:29 ET after hours	Day +1 +132.61% 2024-03-01 Day +5 +130.43% 2024-03-07 Best close within 5 +132.61% 2024-03-01 1.6% of the move was gone five sessions later. Month end +132.61% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $0.4600 to $1.07 as traded Session open, high, low $1.07, $1.08, $1.06 Opening gap +132.61% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 24,676,110 shares, $26,403,438 Relative volume 300.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
5	VKTX	+121.02%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity 02/27/2024 07:03 ET premarket	Day +1 +145.58% 2024-02-28 Day +5 +128.43% 2024-03-05 Best close within 5 +145.58% 2024-02-28 Five sessions later the move was 6.1% bigger, at +128.43%. Month end +100.23% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $38.48 to $85.05 split-adjusted Session open, high, low $69.77, $90.00, $57.56 Opening gap +81.31% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 59,033,668 shares, $5,020,813,463 Relative volume 18.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	ENGN	+116.54%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	enGene Announces Oversubscribed $200 Million Private Placement Financing 02/14/2024 06:50 ET premarket enGene Announces Leadership Succession Plan 02/14/2024	Day +1 +106.04% 2024-02-15 Day +5 +107.87% 2024-02-22 Best close within 5 +111.94% 2024-02-16 7.4% of the move was gone five sessions later. Month end +93.57% on 2024-02-29
Close before and after $7.62 to $16.50 split-adjusted Session open, high, low $13.75, $16.81, $12.08 Opening gap +80.45% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 867,165 shares, $14,308,223 Relative volume 191.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
7	GLT	+106.25%	2024-02-07 against the close of 2024-02-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Berry Global and Glatfelter Announce Plans for Tax-Free Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter, Creating a Global Specialty Materials Leader 02/07/2024 07:00 ET premarket	Day +1 +73.44% 2024-02-08 Day +5 +81.25% 2024-02-14 Best close within 5 +81.25% 2024-02-14 23.5% of the move was gone five sessions later. Month end +74.22% on 2024-02-29
Close before and after $16.64 to $34.32 as traded Session open, high, low $32.89, $35.23, $25.48 Opening gap +97.66% Close inside the session range 0.91 of the range, where 1.00 is the high Session volume 5,131,173 shares, $176,101,857 Relative volume 360.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
8	AKLI	+104.11%	2024-02-26 against the close of 2024-02-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan 02/26/2024 08:47 ET premarket	Day +1 +109.84% 2024-02-27 Day +5 +53.43% 2024-03-04 Best close within 5 +109.84% 2024-02-27 48.7% of the move was gone five sessions later. Month end +73.01% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $0.2216 to $0.4523 as traded Session open, high, low $0.6495, $0.7384, $0.4371 Opening gap +193.10% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 128,377,553 shares, $58,065,167 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
9	NSTG Also on the opposite board this month on both boards	+97.93%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	NanoString Announces Completion of Financing to Support Restructuring Process 02/09/2024 06:30 ET premarket	Day +1 +44.84% 2024-02-12 Day +5 -50.95% 2024-02-16 Best close within 5 +44.84% 2024-02-12 It gave back the whole move and closed 50.95% below the pre-news price. Month end +3.18% on 2024-02-29
Close before and after $0.1162 to $0.2300 as traded Session open, high, low $0.1500, $0.3797, $0.1450 Opening gap +29.09% Close inside the session range 0.36 of the range, where 1.00 is the high Session volume 419,200,402 shares, $96,416,092 Relative volume 542.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	MNPR More than one ranked move this month 2+ ranked moves	+96.49%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers 02/22/2024 07:00 ET premarket	Day +1 +128.07% 2024-02-23 Day +5 +45.61% 2024-02-29 Best close within 5 +136.84% 2024-02-26 52.7% of the move was gone five sessions later. Month end +45.61% on 2024-02-29
Close before and after $2.85 to $5.60 split-adjusted Session open, high, low $3.90, $6.85, $3.65 Opening gap +36.88% Close inside the session range 0.61 of the range, where 1.00 is the high Session volume 30,666,525 shares, $171,732,540 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	GRRR	+96.36%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Gorilla Technology Group Reports Results Through Third Quarter 2023 02/05/2024 08:00 ET premarket	Day +1 +92.76% 2024-02-06 Day +5 +73.84% 2024-02-12 Best close within 5 +101.77% 2024-02-07 23.4% of the move was gone five sessions later. Month end +60.46% on 2024-02-29
Close before and after $5.55 to $10.90 split-adjusted Session open, high, low $6.25, $12.80, $6.12 Opening gap +12.59% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 12,681,734 shares, $138,230,901 Relative volume 459.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
12	VTVT	+95.88%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund 02/28/2024 08:00 ET premarket	Day +1 +106.47% 2024-02-29 Day +5 +72.94% 2024-03-06 Best close within 5 +106.47% 2024-02-29 23.9% of the move was gone five sessions later. Month end +106.47% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $8.50 to $16.65 split-adjusted Session open, high, low $13.10, $23.50, $12.51 Opening gap +54.12% Close inside the session range 0.38 of the range, where 1.00 is the high Session volume 3,062,711 shares, $50,994,138 Relative volume 307.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	MNPR More than one ranked move this month 2+ ranked moves	+95.27%	2024-02-20 against the close of 2024-02-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers 02/20/2024 08:00 ET premarket	Day +1 +66.37% 2024-02-21 Day +5 +253.18% 2024-02-27 Best close within 5 +294.05% 2024-02-26 Five sessions later the move was 165.7% bigger, at +253.18%. Month end +142.27% on 2024-02-29
Close before and after $1.71 to $3.35 split-adjusted Session open, high, low $7.15, $7.80, $2.98 Opening gap +317.40% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 20,076,489 shares, $67,155,856 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
14	FDMT	+84.62%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	4DMT Presents Positive Interim Data from Randomized Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 Demonstrating Favorable Tolerability & Clinical Activity in Wet AMD 02/03/2024 17:00 ET after hours	Day +1 +89.88% 2024-02-06 Day +5 +59.23% 2024-02-12 Best close within 5 +89.88% 2024-02-06 30.0% of the move was gone five sessions later. Month end +60.21% on 2024-02-29
Close before and after $17.49 to $32.29 split-adjusted Session open, high, low $30.05, $35.61, $28.75 Opening gap +71.81% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 19,637,650 shares, $634,099,719 Relative volume 44.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
15	PLCE Also on the opposite board this month release reads negative on both boards	+81.12%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement Release reads negative, stock rose 81.12%	The Children’s Place Provides Shareholder Update 02/15/2024 06:30 ET premarket	Day +1 +100.62% 2024-02-16 Day +5 +40.41% 2024-02-23 Best close within 5 +100.62% 2024-02-16 50.2% of the move was gone five sessions later. Month end +32.55% on 2024-02-29
Close before and after $14.52 to $26.29 split-adjusted Session open, high, low $18.58, $38.03, $18.39 Opening gap +28.01% Close inside the session range 0.40 of the range, where 1.00 is the high Session volume 17,031,550 shares, $447,759,450 Relative volume 36.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	BOF More than one ranked move this month 2+ ranked moves	+80.06%	2024-02-12 against the close of 2024-02-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BranchOut Food Expands Relationship with Nation’s Largest Retailer, Valued at an estimated $7.6M Annually 02/12/2024 08:00 ET premarket	Day +1 +62.64% 2024-02-13 Day +5 +85.51% 2024-02-20 Best close within 5 +90.95% 2024-02-16 Five sessions later the move was 6.8% bigger, at +85.51%. Month end +56.83% on 2024-02-29
Close before and after $1.38 to $2.48 split-adjusted Session open, high, low $1.41, $3.60, $1.30 Opening gap +2.37% Close inside the session range 0.51 of the range, where 1.00 is the high Session volume 2,863,198 shares, $7,100,731 Relative volume 313.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
17	EBS	+78.29%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO 02/21/2024 07:00 ET premarket	Day +1 +84.21% 2024-02-22 Day +5 +110.53% 2024-02-28 Best close within 5 +117.11% 2024-02-27 Five sessions later the move was 41.2% bigger, at +110.53%. Month end +112.50% on 2024-02-29
Close before and after $1.52 to $2.71 split-adjusted Session open, high, low $1.70, $3.25, $1.66 Opening gap +11.84% Close inside the session range 0.66 of the range, where 1.00 is the high Session volume 76,155,055 shares, $206,380,199 Relative volume 62.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
18	TELO	+69.76%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Telomir Pharmaceuticals Announces Closing of Initial Public Offering 02/13/2024 16:05 ET after hours	Day +1 +14.98% 2024-02-15 Day +5 +27.10% 2024-02-22 Best close within 5 +28.67% 2024-02-16 61.2% of the move was gone five sessions later. Month end +29.39% on 2024-02-29
Close before and after $7.01 to $11.90 split-adjusted Session open, high, low $7.50, $20.72, $7.02 Opening gap +6.99% Close inside the session range 0.36 of the range, where 1.00 is the high Session volume 652,206 shares, $7,761,251 Baseline gap 1 calendar day from the pre-news close to the measured session
19	AXTI	+69.30%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AXT, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results 02/22/2024 16:05 ET after hours	Day +1 +98.68% 2024-02-26 Day +5 +87.28% 2024-03-01 Best close within 5 +135.53% 2024-02-27 Five sessions later the move was 25.9% bigger, at +87.28%. Month end +88.16% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $2.28 to $3.86 split-adjusted Session open, high, low $3.16, $4.85, $3.15 Opening gap +38.60% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 103,105,619 shares, $397,987,689 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	MRVI	+63.60%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results 02/22/2024 16:05 ET after hours	Day +1 +57.14% 2024-02-26 Day +5 +48.53% 2024-03-01 Best close within 5 +61.64% 2024-02-27 23.7% of the move was gone five sessions later. Month end +51.27% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $5.11 to $8.36 split-adjusted Session open, high, low $6.95, $8.62, $6.77 Opening gap +36.01% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 25,865,152 shares, $216,232,671 Relative volume 11.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
21	COGT	+59.34%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Cogent Biosciences Announces Oversubscribed $225 Million Private Placement 02/14/2024 07:00 ET premarket	Day +1 +62.64% 2024-02-15 Day +5 +63.92% 2024-02-22 Best close within 5 +65.20% 2024-02-16 Five sessions later the move was 7.7% bigger, at +63.92%. Month end +28.21% on 2024-02-29
Close before and after $5.46 to $8.70 split-adjusted Session open, high, low $8.55, $9.41, $7.95 Opening gap +56.60% Close inside the session range 0.51 of the range, where 1.00 is the high Session volume 10,747,799 shares, $93,505,851 Relative volume 6.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
22	BZFD	+58.10%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	BuzzFeed, Inc. Announces Sale of Complex to NTWRK in All-Cash Deal 02/21/2024 16:05 ET after hours	Day +1 +50.96% 2024-02-23 Day +5 +56.91% 2024-02-29 Best close within 5 +58.65% 2024-02-28 2.0% of the move was gone five sessions later. Month end +56.91% on 2024-02-29
Close before and after $0.8744 to $1.38 split-adjusted Session open, high, low $1.80, $1.95, $1.25 Opening gap +105.86% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 23,173,562 shares, $32,035,132 Relative volume 88.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
23	FHTX	+55.45%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor 02/08/2024 07:00 ET premarket	Day +1 +90.71% 2024-02-09 Day +5 +118.27% 2024-02-15 Best close within 5 +118.27% 2024-02-15 Five sessions later the move was 113.3% bigger, at +118.27%. Month end +147.76% on 2024-02-29
Close before and after $3.12 to $4.85 split-adjusted Session open, high, low $3.57, $5.79, $3.50 Opening gap +14.42% Close inside the session range 0.59 of the range, where 1.00 is the high Session volume 1,681,285 shares, $8,154,232 Relative volume 12.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	SOGP	+53.74%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Sound Group Embraces Generative AI to Unveil New AI-Powered Applications 02/21/2024 06:30 ET premarket	Day +1 +41.57% 2024-02-22 Day +5 +25.57% 2024-02-28 Best close within 5 +41.57% 2024-02-22 52.4% of the move was gone five sessions later. Month end +25.22% on 2024-02-29
Close before and after $2.88 to $4.42 split-adjusted Session open, high, low $4.68, $6.70, $3.90 Opening gap +62.78% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 46,900,666 shares, $207,300,944 Relative volume over 1,000x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	ROOT	+53.29%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Root, Inc. Announces 2023 Fourth Quarter and Full Year Results 02/21/2024 16:15 ET after hours	Day +1 +95.62% 2024-02-23 Day +5 +270.36% 2024-02-29 Best close within 5 +270.36% 2024-02-29 Five sessions later the move was 407.3% bigger, at +270.36%. Month end +270.36% on 2024-02-29
Close before and after $8.67 to $13.29 split-adjusted Session open, high, low $11.64, $14.00, $11.51 Opening gap +34.26% Close inside the session range 0.71 of the range, where 1.00 is the high Session volume 7,277,321 shares, $96,715,596 Relative volume 92.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	BAND	+51.77%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Bandwidth Announces Fourth Quarter and Full Year 2023 Financial Results, Exceeding Revenue and Profitability Guidance 02/28/2024 07:00 ET premarket	Day +1 +69.05% 2024-02-29 Day +5 +60.16% 2024-03-06 Best close within 5 +70.29% 2024-03-01 Five sessions later the move was 16.2% bigger, at +60.16%. Month end +69.05% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $12.15 to $18.44 split-adjusted Session open, high, low $17.71, $18.89, $16.47 Opening gap +45.76% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 2,994,468 shares, $55,217,990 Relative volume 14.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	CNVS Also on the opposite board this month on both boards	+51.61%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Cineverse Partners with Google Cloud to Launch a Conversational AI-Powered Search & Discovery Tool for Film and Television Content 02/14/2024 09:00 ET premarket	Day +1 +6.45% 2024-02-15 Day +5 -9.68% 2024-02-22 Best close within 5 +6.45% 2024-02-15 It gave back the whole move and closed 9.68% below the pre-news price. Month end -14.84% on 2024-02-29
Close before and after $1.55 to $2.35 split-adjusted Session open, high, low $3.18, $3.93, $2.11 Opening gap +105.16% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 32,912,648 shares, $77,344,723 Relative volume 648.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
28	ARM	+47.89%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Arm Holdings plc Reports Results for the Third Quarter of the Financial Year Ending 2024 02/07/2024 16:02 ET after hours	Day +1 +49.60% 2024-02-09 Day +5 +73.59% 2024-02-15 Best close within 5 +93.44% 2024-02-12 Five sessions later the move was 53.7% bigger, at +73.59%. Month end +83.15% on 2024-02-29
Close before and after $77.01 to $113.89 split-adjusted Session open, high, low $94.41, $126.59, $94.00 Opening gap +22.59% Close inside the session range 0.61 of the range, where 1.00 is the high Session volume 106,505,653 shares, $12,129,928,820 Relative volume 15.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
29	MIRA	+45.99%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	MIRA Pharmaceuticals Provides Corporate Update 02/05/2024 08:30 ET premarket	Day +1 +20.43% 2024-02-06 Day +5 +24.73% 2024-02-12 Best close within 5 +25.81% 2024-02-09 46.2% of the move was gone five sessions later. Month end +8.06% on 2024-02-29
Close before and after $0.9300 to $1.36 split-adjusted Session open, high, low $1.04, $1.54, $1.00 Opening gap +11.83% Close inside the session range 0.66 of the range, where 1.00 is the high Session volume 4,937,950 shares, $6,704,255 Relative volume 60.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
30	BLZE	+45.15%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Backblaze Announces Fourth Quarter and Full Year 2023 Financial Results 02/15/2024 16:05 ET after hours	Day +1 +44.05% 2024-02-20 Day +5 +21.72% 2024-02-26 Best close within 5 +44.05% 2024-02-20 51.9% of the move was gone five sessions later. Month end +30.31% on 2024-02-29
Close before and after $8.15 to $11.83 split-adjusted Session open, high, low $9.20, $11.83, $9.00 Opening gap +12.88% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 3,695,824 shares, $43,721,598 Relative volume 16.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	MATV	+42.69%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Mativ Announces Fourth Quarter and Full Year 2023 Results 02/21/2024 16:40 ET after hours	Day +1 +38.78% 2024-02-23 Day +5 +47.70% 2024-02-29 Best close within 5 +47.70% 2024-02-29 Five sessions later the move was 11.7% bigger, at +47.70%. Month end +47.70% on 2024-02-29
Close before and after $11.76 to $16.78 split-adjusted Session open, high, low $12.02, $16.95, $12.02 Opening gap +2.21% Close inside the session range 0.97 of the range, where 1.00 is the high Session volume 1,938,478 shares, $32,527,661 Relative volume 4.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	CRDL	+42.31%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis 02/15/2024 07:27 ET premarket	Day +1 +37.50% 2024-02-16 Day +5 +55.77% 2024-02-23 Best close within 5 +60.58% 2024-02-20 Five sessions later the move was 31.8% bigger, at +55.77%. Month end +98.08% on 2024-02-29
Close before and after $1.04 to $1.48 split-adjusted Session open, high, low $1.23, $1.48, $1.19 Opening gap +18.27% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 3,506,096 shares, $5,189,022 Relative volume 12.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	ONMD	+42.23%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S. 02/29/2024 08:00 ET premarket	Day +1 +15.72% 2024-03-01 Day +5 +16.81% 2024-03-07 Best close within 5 +16.81% 2024-03-07 60.2% of the move was gone five sessions later. Month end +42.23% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $0.6900 to $0.9814 split-adjusted Session open, high, low $0.7100, $1.05, $0.7100 Opening gap +2.90% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 2,480,079 shares, $2,433,950 Relative volume 4.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	JMIA	+41.18%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Jumia Reports Fourth Quarter and Full Year 2023 Results 02/15/2024 08:00 ET premarket	Day +1 +47.06% 2024-02-16 Day +5 +33.13% 2024-02-23 Best close within 5 +47.06% 2024-02-16 19.5% of the move was gone five sessions later. Month end +88.54% on 2024-02-29
Close before and after $3.23 to $4.56 split-adjusted Session open, high, low $3.48, $4.65, $3.36 Opening gap +7.74% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 17,155,164 shares, $78,227,548 Relative volume 19.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	KRYS	+41.02%	2024-02-26 against the close of 2024-02-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates 02/26/2024 08:00 ET premarket	Day +1 +52.83% 2024-02-27 Day +5 +43.67% 2024-03-04 Best close within 5 +52.83% 2024-02-27 Five sessions later the move was 6.5% bigger, at +43.67%. Month end +43.24% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $111.33 to $157.00 split-adjusted Session open, high, low $126.77, $162.28, $125.85 Opening gap +13.87% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 2,237,230 shares, $351,245,110 Relative volume 6.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
36	ACMR	+40.80%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	ACM Research Reports Fourth Quarter and Fiscal Year 2023 Results 02/28/2024 05:00 ET premarket	Day +1 +41.90% 2024-02-29 Day +5 +39.79% 2024-03-06 Best close within 5 +55.62% 2024-03-01 2.5% of the move was gone five sessions later. Month end +41.90% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $21.79 to $30.68 split-adjusted Session open, high, low $25.20, $31.01, $25.17 Opening gap +15.65% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 12,244,428 shares, $375,659,051 Relative volume 10.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	SGMO	+40.15%	2024-02-12 against the close of 2024-02-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease 02/12/2024 08:05 ET premarket	Day +1 +16.66% 2024-02-13 Day +5 +105.43% 2024-02-20 Best close within 5 +140.25% 2024-02-16 Five sessions later the move was 162.6% bigger, at +105.43%. Month end +101.95% on 2024-02-29
Close before and after $0.5744 to $0.8050 as traded Session open, high, low $0.6230, $0.8470, $0.6105 Opening gap +8.46% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 8,501,560 shares, $6,843,756 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
38	MODD	+39.44%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Modular Medical Announces Proposed Public Offering 02/15/2024 16:15 ET after hours Modular Medical Announces Pricing of $10 Million Public Offering 02/15/2024	Day +1 +39.44% 2024-02-20 Day +5 +37.05% 2024-02-26 Best close within 5 +41.83% 2024-02-23 6.1% of the move was gone five sessions later. Month end +57.77% on 2024-02-29
Close before and after $37.65 to $52.50 split-adjusted Session open, high, low $40.50, $57.00, $40.50 Opening gap +7.57% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 78,906 shares, $4,142,565 Relative volume 28.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
39	LASE	+39.42%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Laser Photonics Scores Order from Pima Air & Space Museum for Its CleanTech Laser Cleaning System 02/29/2024 07:00 ET premarket	Day +1 +32.69% 2024-03-01 Day +5 +116.35% 2024-03-07 Best close within 5 +116.35% 2024-03-07 Five sessions later the move was 195.2% bigger, at +116.35%. Month end +39.42% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $1.04 to $1.45 split-adjusted Session open, high, low $1.19, $1.54, $1.05 Opening gap +14.42% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 7,788,906 shares, $11,293,914 Relative volume 339.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
40	WISH	+39.11%	2024-02-12 against the close of 2024-02-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	ContextLogic Announces Agreement to Sell Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10 for $173 Million in Cash 02/12/2024 08:00 ET premarket	Day +1 +39.33% 2024-02-13 Day +5 +53.22% 2024-02-20 Best close within 5 +53.22% 2024-02-20 Five sessions later the move was 36.1% bigger, at +53.22%. Month end +44.44% on 2024-02-29
Close before and after $4.50 to $6.26 as traded Session open, high, low $6.42, $6.88, $6.00 Opening gap +42.67% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 19,193,838 shares, $120,153,426 Relative volume 38.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
41	BRLS	+38.90%	2024-02-07 against the close of 2024-02-06 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	Borealis Foods Inc., a Rapidly Growing, Mission-Driven Food Tech Company, Completes Business Combination and Will Commence Trading on Nasdaq Under the Symbol "BRLS" 02/07/2024 13:41 ET intraday	Day +1 -8.88% 2024-02-08 Day +5 -1.11% 2024-02-14 Best close within 5 +0.01% 2024-02-09 It gave back the whole move and closed 1.11% below the pre-news price. Month end -5.55% on 2024-02-29
Close before and after $9.00 to $12.50 split-adjusted Session open, high, low $7.42, $12.50, $7.20 Opening gap -17.55% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 11,100 shares, $138,750 Relative volume 13.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	GTHX Also on the opposite board this month on both boards	+38.75%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights 02/28/2024 06:30 ET premarket	Day +1 +38.33% 2024-02-29 Day +5 +47.08% 2024-03-06 Best close within 5 +55.42% 2024-03-01 Five sessions later the move was 21.5% bigger, at +47.08%. Month end +38.33% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $2.40 to $3.33 as traded Session open, high, low $2.55, $3.39, $2.50 Opening gap +6.25% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 5,029,985 shares, $16,749,850 Relative volume 3.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
43	VLCN	+38.68%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	Business Update from John Kim New CEO at Volcon Inc 02/28/2024 07:30 ET premarket	Day +1 +52.44% 2024-02-29 Day +5 -0.28% 2024-03-06 Best close within 5 +52.44% 2024-02-29 It gave back the whole move and closed 0.28% below the pre-news price. Month end +52.44% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $5,584.00 to $7,744.00 as traded Session open, high, low $5,557.76, $9,216.00, $5,312.00 Opening gap -0.47% Close inside the session range 0.62 of the range, where 1.00 is the high Session volume 3,339 shares, $25,857,216 Relative volume 15.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	DNLI	+38.25%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Denali Therapeutics Announces $500 million Private Placement Equity Financing 02/27/2024 08:00 ET premarket Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights 02/27/2024	Day +1 +19.66% 2024-02-28 Day +5 +21.08% 2024-03-05 Best close within 5 +23.51% 2024-03-01 44.9% of the move was gone five sessions later. Month end +17.11% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $16.89 to $23.35 split-adjusted Session open, high, low $19.94, $23.52, $18.67 Opening gap +18.06% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 5,089,751 shares, $118,845,686 Relative volume 4.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
45	LRMR	+36.84%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Larimar Therapeutics Announces Proposed Underwritten Public Offering 02/13/2024 16:18 ET after hours Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock 02/14/2024	Day +1 +51.95% 2024-02-15 Day +5 +33.87% 2024-02-22 Best close within 5 +51.95% 2024-02-15 8.1% of the move was gone five sessions later. Month end +31.58% on 2024-02-29
Close before and after $8.74 to $11.96 split-adjusted Session open, high, low $10.84, $12.92, $10.33 Opening gap +24.03% Close inside the session range 0.63 of the range, where 1.00 is the high Session volume 6,092,399 shares, $72,865,092 Relative volume 28.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	SNAL	+36.36%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Snail’s Innovates Development Pipeline with AI Technology 02/27/2024 08:00 ET premarket	Day +1 +36.35% 2024-02-28 Day +5 +18.17% 2024-03-05 Best close within 5 +36.35% 2024-02-28 50.0% of the move was gone five sessions later. Month end +21.58% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $4.40 to $6.00 split-adjusted Session open, high, low $5.00, $6.40, $4.51 Opening gap +13.62% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 353,588 shares, $2,121,705 Relative volume 170.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
47	CTMX	+36.36%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	CytomX Therapeutics to Present at Upcoming March Investor Conferences 02/27/2024 08:00 ET premarket	Day +1 +53.94% 2024-02-28 Day +5 +64.85% 2024-03-05 Best close within 5 +66.06% 2024-03-04 Five sessions later the move was 78.4% bigger, at +64.85%. Month end +48.48% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $1.65 to $2.25 split-adjusted Session open, high, low $1.66, $2.44, $1.66 Opening gap +0.61% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 9,623,256 shares, $21,652,326 Relative volume 55.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	UMAC	+36.34%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Unusual Machines Completes Acquisitions of Fat Shark and Rotor Riot 02/22/2024 16:01 ET after hours	Day +1 +18.89% 2024-02-26 Day +5 +7.19% 2024-03-01 Best close within 5 +34.91% 2024-02-27 80.2% of the move was gone five sessions later. Month end +16.63% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $2.44 to $3.32 split-adjusted Session open, high, low $2.85, $3.47, $2.67 Opening gap +17.04% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 246,633 shares, $818,822 Baseline gap 1 calendar day from the pre-news close to the measured session
49	VGAS	+36.07%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Verde Clean Fuels, Inc. and Cottonmouth Ventures LLC Announce Joint Development Agreement for a Proposed Natural Gas-to-Gasoline Facility in Permian Basin 02/13/2024 07:30 ET premarket	Day +1 +53.93% 2024-02-14 Day +5 +87.50% 2024-02-21 Best close within 5 +91.07% 2024-02-16 Five sessions later the move was 142.6% bigger, at +87.50%. Month end +51.79% on 2024-02-29
Close before and after $2.80 to $3.81 split-adjusted Session open, high, low $2.98, $4.50, $2.98 Opening gap +6.43% Close inside the session range 0.55 of the range, where 1.00 is the high Session volume 354,341 shares, $1,350,039 Relative volume 45.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	PEGA	+35.67%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Pega Delivers Double-Digit ACV Growth and Record Cash Flow in Q4 2023 02/14/2024 16:05 ET after hours	Day +1 +27.94% 2024-02-16 Day +5 +25.66% 2024-02-23 Best close within 5 +27.94% 2024-02-16 28.1% of the move was gone five sessions later. Month end +28.26% on 2024-02-29
Close before and after $25.36 to $34.40 split-adjusted Session open, high, low $30.55, $34.63, $30.00 Opening gap +20.49% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 6,787,750 shares, $233,498,600 Relative volume 9.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	AHG	+35.67%	2024-02-01 against the close of 2024-01-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	AHG Announces Plan to Acquire Online Clinic 01/31/2024 16:00 ET after hours	Day +1 +58.54% 2024-02-02 Day +5 0.00% 2024-02-08 Best close within 5 +58.54% 2024-02-02 100.0% of the move was gone five sessions later. Month end -17.07% on 2024-02-29
Close before and after $1.64 to $2.23 split-adjusted Session open, high, low $1.64, $2.38, $1.57 Opening gap 0.00% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 871,340 shares, $1,938,732 Relative volume 18.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	FREE	+35.33%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Whole Earth Brands Signs Definitive Agreement to be Acquired by Affiliates of Sababa Holdings FREE, LLC 02/13/2024 08:00 ET premarket	Day +1 +35.61% 2024-02-14 Day +5 +36.18% 2024-02-21 Best close within 5 +36.18% 2024-02-21 Five sessions later the move was 2.4% bigger, at +36.18%. Month end +36.18% on 2024-02-29
Close before and after $3.51 to $4.75 as traded Session open, high, low $4.77, $4.77, $4.73 Opening gap +35.90% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 21,913,258 shares, $104,087,976 Relative volume 213.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
53	LYFT	+35.12%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lyft Announces Fourth Quarter and Full-Year 2023 Results 02/13/2024 16:05 ET after hours	Day +1 +56.88% 2024-02-15 Day +5 +31.16% 2024-02-22 Best close within 5 +56.88% 2024-02-15 11.3% of the move was gone five sessions later. Month end +30.92% on 2024-02-29
Close before and after $12.13 to $16.39 split-adjusted Session open, high, low $14.98, $16.77, $14.90 Opening gap +23.50% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 109,310,555 shares, $1,791,599,996 Relative volume 12.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	DOOR	+35.09%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Owens Corning Announces $3.9 Billion Acquisition of Masonite to Strengthen Position in Building and Construction Materials 02/09/2024 07:05 ET premarket	Day +1 +34.56% 2024-02-12 Day +5 +34.27% 2024-02-16 Best close within 5 +34.56% 2024-02-12 2.3% of the move was gone five sessions later. Month end +34.81% on 2024-02-29
Close before and after $96.61 to $130.51 as traded Session open, high, low $129.89, $130.67, $129.60 Opening gap +34.45% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 5,085,675 shares, $663,731,444 Relative volume 17.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	LUNR	+34.54%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	IM-1 Mission Nova-C Lunar Lander Successfully Enroute to the Moon Following its Launch on SpaceX’s Falcon 9 02/15/2024 09:09 ET premarket	Day +1 +46.99% 2024-02-16 Day +5 +92.57% 2024-02-23 Best close within 5 +120.68% 2024-02-20 Five sessions later the move was 168.0% bigger, at +92.57%. Month end +21.08% on 2024-02-29
Close before and after $4.98 to $6.70 split-adjusted Session open, high, low $5.30, $6.96, $5.13 Opening gap +6.43% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 22,997,072 shares, $154,080,382 Relative volume 13.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	AREN	+34.53%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Manoj Bhargava Invests $12 Million More in The Arena Group 02/14/2024 18:25 ET after hours	Day +1 +33.09% 2024-02-16 Day +5 +25.90% 2024-02-23 Best close within 5 +58.27% 2024-02-20 25.0% of the move was gone five sessions later. Month end +38.85% on 2024-02-29
Close before and after $1.39 to $1.87 split-adjusted Session open, high, low $1.35, $1.90, $1.25 Opening gap -2.88% Close inside the session range 0.95 of the range, where 1.00 is the high Session volume 477,707 shares, $893,312 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	ADVM Also on the opposite board this month release reads negative on both boards	+34.51%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution Release reads negative, stock rose 34.51%	Adverum Biotechnologies Announces $127.5 Million Private Placement Financing 02/05/2024 07:45 ET premarket	Day +1 +76.06% 2024-02-06 Day +5 +40.14% 2024-02-12 Best close within 5 +97.89% 2024-02-07 Five sessions later the move was 16.3% bigger, at +40.14%. Month end +39.44% on 2024-02-29
Close before and after $14.20 to $19.10 as traded Session open, high, low $17.10, $20.90, $15.80 Opening gap +20.42% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 2,414,665 shares, $46,120,102 Relative volume 50.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
58	CFLT	+34.09%	2024-02-08 against the close of 2024-02-07 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Confluent Announces Fourth Quarter and Fiscal Year 2023 Financial Results 02/07/2024 16:03 ET after hours	Day +1 +30.59% 2024-02-09 Day +5 +38.74% 2024-02-15 Best close within 5 +39.52% 2024-02-14 Five sessions later the move was 13.6% bigger, at +38.74%. Month end +39.44% on 2024-02-29
Close before and after $24.29 to $32.57 as traded Session open, high, low $31.34, $32.88, $30.11 Opening gap +29.02% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 24,395,205 shares, $794,551,827 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	PYXS	+33.26%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Pyxis Oncology Announces $50 Million Private Placement 02/27/2024 08:00 ET premarket	Day +1 +33.05% 2024-02-28 Day +5 +34.94% 2024-03-05 Best close within 5 +37.87% 2024-03-01 Five sessions later the move was 5.1% bigger, at +34.94%. Month end +33.05% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $4.78 to $6.37 split-adjusted Session open, high, low $5.88, $6.85, $5.06 Opening gap +23.01% Close inside the session range 0.73 of the range, where 1.00 is the high Session volume 5,352,048 shares, $34,092,546 Relative volume 7.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	ATRA	+33.10%	2024-02-01 against the close of 2024-01-31 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Atara Biotherapeutics and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology 01/31/2024 18:30 ET after hours	Day +1 +95.64% 2024-02-02 Day +5 +32.44% 2024-02-08 Best close within 5 +95.64% 2024-02-02 2.0% of the move was gone five sessions later. Month end +24.76% on 2024-02-29
Close before and after $15.59 to $20.75 split-adjusted Session open, high, low $15.61, $20.75, $15.53 Opening gap +0.14% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 311,092 shares, $6,455,159 Relative volume 4.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	PRLD	+33.05%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024 02/15/2024 16:05 ET after hours	Day +1 +19.54% 2024-02-20 Day +5 +17.53% 2024-02-26 Best close within 5 +19.54% 2024-02-20 47.0% of the move was gone five sessions later. Month end +23.56% on 2024-02-29
Close before and after $3.48 to $4.63 split-adjusted Session open, high, low $3.50, $4.75, $3.49 Opening gap +0.57% Close inside the session range 0.90 of the range, where 1.00 is the high Session volume 433,582 shares, $2,007,485 Relative volume 7.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	SMCI	+32.87%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Supermicro Announces Proposed Offering of $1.5 Billion of Convertible Senior Notes Due 2029 02/21/2024 17:09 ET after hours	Day +1 +17.14% 2024-02-23 Day +5 +17.97% 2024-02-29 Best close within 5 +19.36% 2024-02-26 45.3% of the move was gone five sessions later. Month end +17.97% on 2024-02-29
Close before and after $73.42 to $97.55 split-adjusted Session open, high, low $86.50, $100.35, $83.40 Opening gap +17.82% Close inside the session range 0.83 of the range, where 1.00 is the high Session volume 253,726,990 shares, $24,751,575,328 Relative volume 2.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	CLSK	+32.86%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	CleanSpark Reports First Quarter FY2024 Financial Results 02/08/2024 16:00 ET after hours	Day +1 +52.43% 2024-02-12 Day +5 +70.10% 2024-02-16 Best close within 5 +70.10% 2024-02-16 Five sessions later the move was 113.3% bigger, at +70.10%. Month end +59.24% on 2024-02-29
Close before and after $10.50 to $13.95 split-adjusted Session open, high, low $13.02, $14.59, $11.95 Opening gap +24.00% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 89,228,018 shares, $1,244,730,851 Relative volume 4.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	WGS	+32.63%	2024-02-21 against the close of 2024-02-20 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024 02/20/2024 16:26 ET after hours	Day +1 +56.58% 2024-02-22 Day +5 +47.90% 2024-02-28 Best close within 5 +56.58% 2024-02-22 Five sessions later the move was 46.8% bigger, at +47.90%. Month end +55.53% on 2024-02-29
Close before and after $5.24 to $6.95 split-adjusted Session open, high, low $4.94, $7.11, $4.61 Opening gap -5.73% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 747,831 shares, $5,197,425 Relative volume 5.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	TELL	+32.57%	2024-02-06 against the close of 2024-02-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Tellurian Explores Sale of Haynesville Upstream Assets 02/06/2024 07:00 ET premarket	Day +1 +36.66% 2024-02-07 Day +5 +74.51% 2024-02-13 Best close within 5 +79.89% 2024-02-09 Five sessions later the move was 128.8% bigger, at +74.51%. Month end +120.47% on 2024-02-29
Close before and after $0.3601 to $0.4774 as traded Session open, high, low $0.3679, $0.4979, $0.3669 Opening gap +2.17% Close inside the session range 0.84 of the range, where 1.00 is the high Session volume 84,054,059 shares, $40,127,408 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
66	WATT	+32.30%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	WiGL and Energous Announce Developmental Milestone to Bring Touchless Wireless Power Transfer Networks to Market 02/15/2024 09:30 ET intraday	Day +1 +25.06% 2024-02-16 Day +5 +3.62% 2024-02-23 Best close within 5 +25.06% 2024-02-16 88.8% of the move was gone five sessions later. Month end +8.53% on 2024-02-29
Close before and after $58.05 to $76.80 split-adjusted Session open, high, low $58.20, $82.50, $58.20 Opening gap +0.26% Close inside the session range 0.77 of the range, where 1.00 is the high Session volume 26,865 shares, $2,063,232 Relative volume 32.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	VERX release reads negative	+32.20%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings Release reads negative, stock rose 32.20%	Vertex Announces Fourth Quarter and Full Year 2023 Financial Results 02/29/2024 07:00 ET premarket	Day +1 +32.09% 2024-03-01 Day +5 +17.52% 2024-03-07 Best close within 5 +32.09% 2024-03-01 45.6% of the move was gone five sessions later. Month end +32.20% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $25.40 to $33.58 split-adjusted Session open, high, low $31.00, $34.19, $30.72 Opening gap +22.05% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 2,939,310 shares, $98,702,030 Relative volume 10.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
68	BLNK	+32.09%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BLINK CHARGING ANNOUNCES PRELIMINARY FULL-YEAR 2023 REVENUE IN EXCESS OF $140 MILLION, REITERATES ADJUSTED EBITDA PROFITABILITY TARGET 02/14/2024 07:45 ET premarket	Day +1 +30.22% 2024-02-15 Day +5 +8.58% 2024-02-22 Best close within 5 +30.22% 2024-02-15 73.3% of the move was gone five sessions later. Month end +18.66% on 2024-02-29
Close before and after $2.68 to $3.54 split-adjusted Session open, high, low $3.16, $3.55, $2.97 Opening gap +17.91% Close inside the session range 0.98 of the range, where 1.00 is the high Session volume 26,593,276 shares, $94,140,197 Relative volume 4.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	CVNA	+32.09%	2024-02-23 against the close of 2024-02-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Carvana Announces Record Fourth Quarter and Full Year 2023 Results 02/22/2024 16:10 ET after hours	Day +1 +33.33% 2024-02-26 Day +5 +58.29% 2024-03-01 Best close within 5 +58.29% 2024-03-01 Five sessions later the move was 81.6% bigger, at +58.29%. Month end +44.88% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $10.48 to $13.85 split-adjusted Session open, high, low $13.57, $15.27, $13.29 Opening gap +29.43% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 195,305,840 shares, $2,704,204,661 Relative volume 6.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	IOVA	+31.48%	2024-02-20 against the close of 2024-02-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock 02/20/2024 06:30 ET premarket Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 02/16/2024	Day +1 +72.35% 2024-02-21 Day +5 +90.93% 2024-02-27 Best close within 5 +90.93% 2024-02-27 Five sessions later the move was 188.9% bigger, at +90.93%. Month end +73.88% on 2024-02-29
Close before and after $9.15 to $12.03 split-adjusted Session open, high, low $11.65, $13.41, $11.31 Opening gap +27.32% Close inside the session range 0.34 of the range, where 1.00 is the high Session volume 58,801,001 shares, $707,376,042 Relative volume 10.8x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
71	MNY	+31.43%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	MoneyHero Group Announces Resignation of Chief Financial Officer 02/08/2024 16:30 ET after hours	Day +1 +26.43% 2024-02-12 Day +5 +50.00% 2024-02-16 Best close within 5 +50.00% 2024-02-16 Five sessions later the move was 59.1% bigger, at +50.00%. Month end +54.29% on 2024-02-29
Close before and after $1.40 to $1.84 split-adjusted Session open, high, low $1.36, $2.20, $1.24 Opening gap -2.86% Close inside the session range 0.63 of the range, where 1.00 is the high Session volume 5,526,371 shares, $10,168,523 Relative volume 58.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	TENX Also on the opposite board this month on both boards	+31.31%	2024-02-06 against the close of 2024-02-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) 02/06/2024 08:30 ET premarket	Day +1 +63.53% 2024-02-07 Day +5 -49.43% 2024-02-13 Best close within 5 +63.53% 2024-02-07 It gave back the whole move and closed 49.43% below the pre-news price. Month end -47.36% on 2024-02-29
Close before and after $8.72 to $11.45 split-adjusted Session open, high, low $20.31, $21.46, $10.70 Opening gap +132.91% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 9,428,121 shares, $107,951,985 Relative volume 369.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	AHCO	+31.06%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook 02/27/2024 07:00 ET premarket	Day +1 +34.60% 2024-02-28 Day +5 +35.91% 2024-03-05 Best close within 5 +38.66% 2024-03-04 Five sessions later the move was 15.6% bigger, at +35.91%. Month end +34.08% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $7.63 to $10.00 split-adjusted Session open, high, low $8.91, $10.17, $8.69 Opening gap +16.78% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 5,651,870 shares, $56,518,700 Relative volume 6.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	HIMS	+31.02%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results 02/26/2024 16:05 ET after hours	Day +1 +30.05% 2024-02-28 Day +5 +38.93% 2024-03-05 Best close within 5 +43.41% 2024-03-04 Five sessions later the move was 25.5% bigger, at +38.93%. Month end +27.22% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $10.25 to $13.43 split-adjusted Session open, high, low $12.33, $13.92, $11.38 Opening gap +20.29% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 34,615,273 shares, $464,883,116 Relative volume 14.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	OSS	+30.82%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	OSS to Present at the 36th Annual ROTH Conference, March 17-19, 2024 02/22/2024 08:31 ET premarket	Day +1 +23.30% 2024-02-23 Day +5 +17.20% 2024-02-29 Best close within 5 +30.47% 2024-02-27 44.2% of the move was gone five sessions later. Month end +17.20% on 2024-02-29
Close before and after $2.79 to $3.65 split-adjusted Session open, high, low $2.98, $4.15, $2.90 Opening gap +6.81% Close inside the session range 0.60 of the range, where 1.00 is the high Session volume 2,016,645 shares, $7,360,754 Relative volume 109.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	PLTR	+30.80%	2024-02-06 against the close of 2024-02-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Palantir Reports Its Fifth Consecutive Quarter of GAAP Profitability; Fourth Quarter GAAP EPS of $0.04 02/05/2024 16:05 ET after hours	Day +1 +41.15% 2024-02-07 Day +5 +43.60% 2024-02-13 Best close within 5 +49.82% 2024-02-12 Five sessions later the move was 41.6% bigger, at +43.60%. Month end +50.00% on 2024-02-29
Close before and after $16.72 to $21.87 split-adjusted Session open, high, low $20.30, $22.18, $19.76 Opening gap +21.41% Close inside the session range 0.87 of the range, where 1.00 is the high Session volume 421,220,485 shares, $9,212,092,007 Relative volume 10.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
77	BYND	+30.72%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Beyond Meat® Reports Fourth Quarter and Full Year 2023 Financial Results 02/27/2024 16:05 ET after hours	Day +1 +42.15% 2024-02-29 Day +5 +7.31% 2024-03-06 Best close within 5 +42.15% 2024-02-29 76.2% of the move was gone five sessions later. Month end +42.15% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $225.60 to $294.90 split-adjusted Session open, high, low $339.00, $363.60, $288.60 Opening gap +50.27% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 1,492,198 shares, $440,049,190 Relative volume 20.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
78	GOTU	+30.64%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results 02/27/2024 02:00 ET premarket	Day +1 +28.62% 2024-02-28 Day +5 +24.58% 2024-03-05 Best close within 5 +36.20% 2024-03-01 19.8% of the move was gone five sessions later. Month end +31.65% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $5.94 to $7.76 split-adjusted Session open, high, low $5.87, $8.13, $5.68 Opening gap -1.18% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 32,689,406 shares, $253,669,791 Relative volume 5.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	UAVS	+30.36%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	AgEagle Aerial Systems Appoints Seasoned Defense Industry Executive William Irby as President 02/15/2024 08:00 ET premarket	Day +1 +24.11% 2024-02-16 Day +5 +2.68% 2024-02-23 Best close within 5 +24.11% 2024-02-16 91.2% of the move was gone five sessions later. Month end +15.18% on 2024-02-29
Close before and after $56.00 to $73.00 split-adjusted Session open, high, low $57.00, $75.00, $56.95 Opening gap +1.79% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 14,597 shares, $1,065,581 Relative volume 3.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	LFST	+30.00%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	LifeStance Reports Fourth Quarter and Full Year 2023 Results 02/28/2024 06:00 ET premarket	Day +1 +24.63% 2024-02-29 Day +5 +8.06% 2024-03-06 Best close within 5 +24.63% 2024-02-29 73.1% of the move was gone five sessions later. Month end +24.63% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $6.70 to $8.71 split-adjusted Session open, high, low $8.06, $9.20, $7.81 Opening gap +20.30% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 11,525,238 shares, $100,384,823 Relative volume 10.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	CDXS	+29.69%	2024-02-27 against the close of 2024-02-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche 02/26/2024 16:05 ET after hours	Day +1 +16.25% 2024-02-28 Day +5 +17.50% 2024-03-05 Best close within 5 +45.31% 2024-02-29 41.1% of the move was gone five sessions later. Month end +45.31% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $3.20 to $4.15 split-adjusted Session open, high, low $3.41, $4.43, $3.24 Opening gap +6.56% Close inside the session range 0.76 of the range, where 1.00 is the high Session volume 2,891,802 shares, $12,000,978 Relative volume 6.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	BOF More than one ranked move this month 2+ ranked moves	+29.56%	2024-02-26 against the close of 2024-02-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	BranchOut Food Significantly Expands Relationship with Nation's Largest Warehouse Club with New Orders Adding ~$900,000 in Q3 of 2024 02/26/2024 08:00 ET premarket	Day +1 +17.72% 2024-02-27 Day +5 +12.07% 2024-03-04 Best close within 5 +20.69% 2024-02-28 59.2% of the move was gone five sessions later. Month end +6.40% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $2.03 to $2.63 split-adjusted Session open, high, low $2.14, $2.76, $2.11 Opening gap +5.42% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 106,817 shares, $280,929 Relative volume 4.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
83	CADL	+29.50%	2024-02-13 against the close of 2024-02-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma 02/13/2024 07:30 ET premarket	Day +1 +21.58% 2024-02-14 Day +5 +26.62% 2024-02-21 Best close within 5 +26.62% 2024-02-21 9.8% of the move was gone five sessions later. Month end +33.81% on 2024-02-29
Close before and after $1.39 to $1.80 split-adjusted Session open, high, low $1.49, $1.94, $1.44 Opening gap +7.19% Close inside the session range 0.72 of the range, where 1.00 is the high Session volume 1,932,602 shares, $3,478,684 Relative volume 103.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	TYRA	+29.29%	2024-02-02 against the close of 2024-02-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia 02/01/2024 17:30 ET after hours Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing 02/02/2024	Day +1 +32.59% 2024-02-05 Day +5 +41.58% 2024-02-09 Best close within 5 +41.58% 2024-02-09 Five sessions later the move was 42.0% bigger, at +41.58%. Month end +53.65% on 2024-02-29
Close before and after $13.01 to $16.82 split-adjusted Session open, high, low $14.65, $17.20, $14.55 Opening gap +12.61% Close inside the session range 0.86 of the range, where 1.00 is the high Session volume 1,175,890 shares, $19,778,470 Relative volume 24.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	AGTI	+29.06%	2024-02-26 against the close of 2024-02-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Agiliti to Be Taken Private by THL Partners 02/26/2024 08:00 ET premarket	Day +1 +29.32% 2024-02-27 Day +5 +29.45% 2024-03-04 Best close within 5 +29.58% 2024-03-01 Five sessions later the move was 1.3% bigger, at +29.45%. Month end +29.19% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $7.64 to $9.86 as traded Session open, high, low $9.88, $9.90, $9.85 Opening gap +29.32% Close inside the session range 0.20 of the range, where 1.00 is the high Session volume 31,049,573 shares, $306,148,790 Relative volume 159.5x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
86	ASPI	+29.03%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	ASP Isotopes Inc. Announces Increase in Offering Size of Convertible Notes by Quantum Leap Energy 02/22/2024 13:49 ET intraday	Day +1 +22.58% 2024-02-23 Day +5 +22.90% 2024-02-29 Best close within 5 +31.61% 2024-02-26 21.1% of the move was gone five sessions later. Month end +22.90% on 2024-02-29
Close before and after $3.10 to $4.00 split-adjusted Session open, high, low $3.14, $4.00, $3.14 Opening gap +1.29% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 1,532,388 shares, $6,129,552 Relative volume 4.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	OCUL	+28.99%	2024-02-22 against the close of 2024-02-21 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution Rose on dilution	Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement 02/22/2024 07:31 ET premarket Ocular Therapeutix™ Announces Board of Directors and Leadership Updates 02/22/2024 Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer 02/22/2024	Day +1 +31.12% 2024-02-23 Day +5 +33.78% 2024-02-29 Best close within 5 +33.78% 2024-02-29 Five sessions later the move was 16.5% bigger, at +33.78%. Month end +33.78% on 2024-02-29
Close before and after $7.52 to $9.70 split-adjusted Session open, high, low $9.08, $9.91, $8.83 Opening gap +20.74% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 11,046,587 shares, $107,151,894 Relative volume 8.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	WIMI	+28.98%	2024-02-16 against the close of 2024-02-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Crypto & Treasury	WiMi Announced MHConsensus Blockchain Algorithm Achieving Efficient Data Management 02/16/2024 08:30 ET premarket	Day +1 +20.70% 2024-02-20 Day +5 +42.00% 2024-02-26 Best close within 5 +50.28% 2024-02-21 Five sessions later the move was 44.9% bigger, at +42.00%. Month end +33.71% on 2024-02-29
Close before and after $8.45 to $10.90 split-adjusted Session open, high, low $8.76, $11.50, $8.26 Opening gap +3.61% Close inside the session range 0.81 of the range, where 1.00 is the high Session volume 710,530 shares, $7,744,777 Relative volume 56.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
89	FROG	+28.44%	2024-02-15 against the close of 2024-02-14 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	JFrog Announces Fourth Quarter and Fiscal 2023 Results 02/14/2024 16:05 ET after hours	Day +1 +20.87% 2024-02-16 Day +5 +16.96% 2024-02-23 Best close within 5 +20.87% 2024-02-16 40.4% of the move was gone five sessions later. Month end +20.76% on 2024-02-29
Close before and after $37.09 to $47.64 split-adjusted Session open, high, low $46.00, $48.81, $44.25 Opening gap +24.02% Close inside the session range 0.74 of the range, where 1.00 is the high Session volume 10,412,595 shares, $496,056,026 Relative volume 11.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	VTYX release reads negative	+28.43%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings Release reads negative, stock rose 28.43%	Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate Progress 02/27/2024 16:01 ET after hours	Day +1 +17.02% 2024-02-29 Day +5 +47.93% 2024-03-06 Best close within 5 +48.76% 2024-03-04 Five sessions later the move was 68.6% bigger, at +47.93%. Month end +17.02% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $6.05 to $7.77 as traded Session open, high, low $6.60, $8.84, $6.29 Opening gap +9.09% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 15,976,530 shares, $124,137,638 Relative volume 10.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
91	AGFY	+28.10%	2024-02-29 against the close of 2024-02-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Agrify Corporation Announces $3.4 Million Sales Order From New Jersey Woman-Owned Business HarvestWorks Farm 02/29/2024 07:30 ET premarket	Day +1 +23.51% 2024-03-01 Day +5 -11.36% 2024-03-07 Best close within 5 +23.51% 2024-03-01 It gave back the whole move and closed 11.36% below the pre-news price. Month end +28.10% on 2024-02-29 same session This month ended before the fifth session after the move.
Close before and after $7.26 to $9.30 as traded Session open, high, low $8.78, $11.25, $7.76 Opening gap +20.89% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 1,594,863 shares, $14,832,226 Relative volume 63.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	SPIR	+28.10%	2024-02-09 against the close of 2024-02-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Spire Global and Signal Ocean Collaborate to Drive Digitalization of the Maritime Economy; Signal Ocean to Make $10 Million Strategic Investment in Spire Global 02/08/2024 16:05 ET after hours Spire Global Schedules Fourth Quarter and Full Year 2023 Results Conference Call 02/09/2024	Day +1 +38.53% 2024-02-12 Day +5 +44.05% 2024-02-16 Best close within 5 +46.01% 2024-02-15 Five sessions later the move was 56.8% bigger, at +44.05%. Month end +52.15% on 2024-02-29
Close before and after $8.15 to $10.44 split-adjusted Session open, high, low $8.50, $10.44, $8.50 Opening gap +4.29% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 699,426 shares, $7,302,007 Relative volume 9.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	KULR	+27.76%	2024-02-20 against the close of 2024-02-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	KULR Extends Outstanding Note Through End of 2024; Files 14C Disclosing Corporate Actions 02/20/2024 08:30 ET premarket KULR Receives Non-Compliance Notice from NYSE American 02/16/2024	Day +1 +4.48% 2024-02-21 Day +5 +0.07% 2024-02-27 Best close within 5 +4.48% 2024-02-21 99.7% of the move was gone five sessions later. Month end +12.01% on 2024-02-29
Close before and after $1.07 to $1.37 split-adjusted Session open, high, low $1.11, $1.52, $1.09 Opening gap +3.13% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 617,738 shares, $846,054 Relative volume 5.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
94	CLDX	+27.76%	2024-02-26 against the close of 2024-02-23 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria 02/24/2024 14:05 ET intraday Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update 02/26/2024	Day +1 +35.21% 2024-02-27 Day +5 +34.33% 2024-03-04 Best close within 5 +37.43% 2024-03-01 Five sessions later the move was 23.7% bigger, at +34.33%. Month end +27.31% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $37.75 to $48.23 split-adjusted Session open, high, low $39.22, $48.96, $38.96 Opening gap +3.89% Close inside the session range 0.93 of the range, where 1.00 is the high Session volume 4,816,410 shares, $232,295,454 Relative volume 7.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
95	HCSG	+27.17%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	HCSG Reports Q4 2023 Results 02/14/2024 07:00 ET premarket	Day +1 +31.29% 2024-02-15 Day +5 +28.96% 2024-02-22 Best close within 5 +31.29% 2024-02-15 Five sessions later the move was 6.6% bigger, at +28.96%. Month end +34.88% on 2024-02-29
Close before and after $9.46 to $12.03 split-adjusted Session open, high, low $11.90, $12.12, $10.66 Opening gap +25.79% Close inside the session range 0.94 of the range, where 1.00 is the high Session volume 1,776,010 shares, $21,365,400 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
96	CRVO	+27.12%	2024-02-12 against the close of 2024-02-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	CervoMed Publishes Positive Results from AscenD-LB Phase 2a Trial in Peer-Reviewed Journal that Supports the Therapeutic Potential of Neflamapimod in Dementia with Lewy Bodies 02/12/2024 08:00 ET premarket	Day +1 +28.57% 2024-02-13 Day +5 +42.40% 2024-02-20 Best close within 5 +52.69% 2024-02-16 Five sessions later the move was 56.3% bigger, at +42.40%. Month end +24.93% on 2024-02-29
Close before and after $10.99 to $13.97 split-adjusted Session open, high, low $11.65, $14.60, $11.49 Opening gap +6.01% Close inside the session range 0.80 of the range, where 1.00 is the high Session volume 55,729 shares, $778,534 Relative volume 7.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
97	HYLN	+27.03%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Hyliion Holdings Reports Fourth-Quarter and Full-Year 2023 Financial Results 02/13/2024 16:30 ET after hours	Day +1 +38.74% 2024-02-15 Day +5 +13.51% 2024-02-22 Best close within 5 +39.64% 2024-02-16 50.0% of the move was gone five sessions later. Month end +63.96% on 2024-02-29
Close before and after $1.11 to $1.41 split-adjusted Session open, high, low $1.10, $1.45, $1.10 Opening gap -0.90% Close inside the session range 0.89 of the range, where 1.00 is the high Session volume 3,842,325 shares, $5,417,678 Relative volume 3.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	ELMD	+26.92%	2024-02-14 against the close of 2024-02-13 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter 02/13/2024 16:05 ET after hours	Day +1 +32.84% 2024-02-15 Day +5 +43.00% 2024-02-22 Best close within 5 +48.82% 2024-02-21 Five sessions later the move was 59.7% bigger, at +43.00%. Month end +49.90% on 2024-02-29
Close before and after $10.14 to $12.87 split-adjusted Session open, high, low $11.15, $12.95, $11.15 Opening gap +9.96% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 125,843 shares, $1,619,599 Relative volume 19.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	COCH	+26.75%	2024-02-05 against the close of 2024-02-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Envoy Medical CEO Brent Lucas Interviewed by Leading Healthcare Podcast Medical Alley 02/05/2024 11:00 ET intraday	Day +1 +26.32% 2024-02-06 Day +5 +13.16% 2024-02-12 Best close within 5 +26.32% 2024-02-06 50.8% of the move was gone five sessions later. Month end +313.16% on 2024-02-29
Close before and after $1.14 to $1.45 split-adjusted Session open, high, low $1.14, $1.73, $1.14 Opening gap 0.00% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 49,079 shares, $70,919 Relative volume 2.3x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
100	TGTX	+26.74%	2024-02-28 against the close of 2024-02-27 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results 02/28/2024 07:00 ET premarket	Day +1 +23.80% 2024-02-29 Day +5 +31.06% 2024-03-06 Best close within 5 +31.06% 2024-03-06 Five sessions later the move was 16.2% bigger, at +31.06%. Month end +23.80% on 2024-02-29 This month ended before the fifth session after the move.
Close before and after $13.91 to $17.63 split-adjusted Session open, high, low $16.18, $18.89, $15.90 Opening gap +16.32% Close inside the session range 0.58 of the range, where 1.00 is the high Session volume 16,649,222 shares, $293,525,784 Relative volume 4.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 737 smaller events this month are held out of this month's eligible pool; switch to include them. 267 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

4 candidate events for this board could not be anchored to a trading session and are not listed.

1 event was left out of this board because the stored move and the session's own closing prices disagree by far more than a measurement difference, so neither figure could be published.

3 events were left out of this board because the vendor names the ticker as a preferred, a note, a depositary share or a fund rather than a company's common stock.

1 event was left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In February 2024, the median gainer had given back 4.3% of its move five sessions later; the largest catalyst group was Earnings, 31 of the 100 events, at a median of +33.1%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still above the pre-news close at day +5
Earnings	31	31.0%	+33.1%	+38.9%	100.0% of 31
Other Announcement	23	23.0%	+34.5%	+25.6%	87.0% of 23
Offering / Dilution	12	12.0%	+35.7%	+36.0%	100.0% of 12
Clinical Trial Results	10	10.0%	+89.9%	+54.6%	100.0% of 10
M&A / Acquisition	9	9.0%	Fewer than 10 events in this group, so no figures are shown.

6 other catalyst types, 15 events: Contract / Partnership, Leadership Change, FDA & Regulatory, Reverse Merger / Shell, Uplisting / Compliance, Crypto & Treasury.

How much of the move survived

Horizon	Still above the pre-news close close to close	Median change since the measured close as a share of the move
Day +1	99.0% of 100	0.2% given back, of 100
Day +5	93.0% of 100	4.3% given back, of 100
Month end	95.8% of 95	1.1% given back, of 95
Month end falls before day +5 for 29 of these 95 events, so this row is not a later horizon than the one above it. 95 of the 100 events have a month-end close later than the measured session; 5 have it on the measured session itself.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside February 2024

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Best move
MNPR	2Clinical Trial Results	+96.49%
BOF	2Other Announcement	+80.06%

Also risen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Best move
CNXA	2024-01, 2023-12	+101.21%
SIDU	2024-01, 2023-12	+163.16%
SHOT	2024-01, 2023-11	+34.91%
GNS	2024-01, 2023-12	+28.77%
AXGN	2024-01, 2023-11	+36.90%
LAES	2024-01, 2023-12	+21.87%
HRTX	2024-01, 2023-11	+59.26%
XOS	2024-01, 2023-11	+30.90%
SLDB	2023-12, 2023-11	+68.42%
PAPL	2023-12, 2023-11	+50.68%
PRCH	2023-12, 2023-11	+34.35%
CVRX	2023-12, 2023-11	+29.30%
LASEthis month too	2023-12, 2023-11	+30.32%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

2 events have too little trading history for a relative volume, and are not in the tiers above.

Industry

36 other industries, 43 events

Industry not known: 12.0%

4 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against January 2024

100 events in the comparable window.

January 2024 median +26.7%, selected from the 8,201 events in that month's eligible pool

February 2024 median +35.7%, 9.0 points above January 2024. February 2024's median is taken over the 100 ranked rows, selected from the 9,696 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.